NCT06750640

Brief Summary

Modern studies have confirmed that skin temperature changes at acupoints when the body is under pathological conditions. This suggests that changes in the thermal radiation characteristics of acupoints can objectively respond to the symptoms of a disease. In this study, the investigators first evaluated reproducibility of acupoint temperature measurement by IRT. Secondly, the investigators explored the thermal radiation characteristics of MDD-related acupoints, built the diagnostic model for adolescent depression severity and the diagnostic model for MDD in adolescents based on acupoint temperature. Our research findings will provide new ideas, methods and visualisations for early screening, auxiliary diagnosis and condition assessment of MDD in adolescents.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 5, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

December 20, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 27, 2024

Completed
Last Updated

December 31, 2024

Status Verified

December 1, 2024

Enrollment Period

2.3 years

First QC Date

December 20, 2024

Last Update Submit

December 27, 2024

Conditions

Keywords

Major Depression Disorderacupoint temperatureadolescent

Outcome Measures

Primary Outcomes (1)

  • Acupoint emperature

    Temperature of acupoints was measured by infrared thermography (IRT). IRT was not be performed on female subjects during their menstrual and ovulatory periods.

    Baseline

Secondary Outcomes (1)

  • The Self-Rating Depression Scale (SDS) Scores

    Baseline

Study Arms (2)

Healthy Control group

There were 40 healthy control participants in the Healthy Control group.

Diagnostic Test: Infrared thermography

Major Depression Disorder group

There were 60 MDD patients in the MDD group. All MDD adolescents received at least one IRT test. 26 MDD adolescents were detected by 2 investigators and 2 investigators both made 2 independent measurements in a week. 30 MDD subjects were detected the bilateral same name acupoint temperatures.

Diagnostic Test: Infrared thermography

Interventions

Infrared thermographyDIAGNOSTIC_TEST

A thermograph (NEC InfRec R450, Avio Infrared Technologies Co., Ltd., Tokyo) was used to record thermal images. The infrared camera was fixed on a tripod 1 m away from the subject to ensure that no shaking movements or vibrations occurred during the recording of thermal images. MDD related acupoints on the inner and outer sides of the limbs were detected. Appropriate body position was selected according to the different parts to be detected. Using the automatic interval saving shooting mode, one thermal picture was taken at 10-s intervals, 3 pictures were taken for each subject.

Healthy Control groupMajor Depression Disorder group

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The diagnostic criteria of MDD were based on criteria proposed by the International Classification of Diseases 10th Edition (ICD-10). Healthy control participants were determined by a recent depression screening report for confirming their mental health conditions.

You may qualify if:

  • years≤ age\<18 years;
  • SDS score \<53;
  • Adolescents with normal cognitive function can cooperate with the study;
  • Adolescents and guardians agree to the study plan and sign the informed consent form.
  • years≤ age\<18 years;
  • Self-rating Depression Scale (SDS) score ≥ 53;
  • Language, cognition and communication ability are normal;
  • Patients and guardians agree to the study plan and sign the informed consent form.

You may not qualify if:

  • Severe anxiety, schizophrenia, or other serious mental illnesses;
  • There are pigmentation, redness, infection or scarring on the skin at the site of detection;
  • Patients with severe systemic diseases and their complications, serious infections, and major diseases of viscera, tissues, and systems;
  • Female patients who were pregnant or lactating;
  • Female patients who were during, or in proximity (±2 days) to their menstruation or ovulation;
  • Patients with a body temperature ≥37.3°C;
  • Inability to cooperate during the examination;
  • Participating in any other clinical trials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the Third affiliated hospital of Zhejiang Chinese Medical university

Hangzhou, Zhejiang, China

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

December 20, 2024

First Posted

December 27, 2024

Study Start

March 5, 2022

Primary Completion

June 30, 2024

Study Completion

November 30, 2024

Last Updated

December 31, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations